Evidence map›Paper›PMID 39495799›Full record

ArticlePLoS pathogens2024

CD4+ but not CD8+ T cells are required for protection against severe guinea pig cytomegalovirus infections.

Tyler B Rollman, Zachary W Berkebile, Dustin M Hicks, Jason S Hatfield, Priyanka Chauhan, Marco Pravetoni, Mark R Schleiss, Gregg N Milligan, Terry K Morgan, Craig J Bierle

Abstract read
In one paragraph

Article in PLoS pathogens, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Tyler B RollmanDivision of Pediatric Infectious Diseases, Department of Pediatrics, University of Minnesota, Minneapolis, Minnesota, United States of America.
Zachary W BerkebileDivision of Pediatric Infectious Diseases, Department of Pediatrics, University of Minnesota, Minneapolis, Minnesota, United States of America.
Dustin M HicksDepartment of Pharmacology, University of Minnesota, Minneapolis, Minnesota, United States of America.
Jason S HatfieldDivision of Pediatric Infectious Diseases, Department of Pediatrics, University of Minnesota, Minneapolis, Minnesota, United States of America.
Priyanka ChauhanDivision of Pediatric Infectious Diseases, Department of Pediatrics, University of Minnesota, Minneapolis, Minnesota, United States of America.
Marco PravetoniCenter for Medication Development for Substance Use Disorders and Department of Psychiatry and Behavioral Sciences, University of Washington School of Medicine, Seattle, Washington, United States of America.
Mark R SchleissDivision of Pediatric Infectious Diseases, Department of Pediatrics, University of Minnesota, Minneapolis, Minnesota, United States of America.
Gregg N MilliganDivision of Vaccinology, Department of Pediatrics, University of Texas Medical Branch, Galveston, Texas, United States of America.
Terry K MorganDepartment of Pathology, Oregon Health & Science University, Portland, Oregon, United States of America.
Craig J BierleDivision of Pediatric Infectious Diseases, Department of Pediatrics, University of Minnesota, Minneapolis, Minnesota, United States of America.ORCID 0000-0002-7890-7409

Funding

University of Minnesota Clinical and Translational Science Institute (UMN CTSI)UM1TR004405 · NCATS · UNIVERSITY OF MINNESOTA · PI Bruce R Blazar, Damien A Fair · 2023 to 2026
$30.8M
Valacyclovir Phase I TrialU54AI150225 · NIAID · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI MUGAVERO, MICHAEL J · 2019 to 2024
$7.6M
Optimizing Immunity and Maternal Host Defense Against Congenital Cytomegalovirus InfectionR01HD098866 · NICHD · UNIVERSITY OF MINNESOTA · PI Craig John Bierle, Michael A McVoy · 2019 to 2026
$3.9M
Trophoblast development and placental susceptibility to cytomegalovirus infectionR01HD109252 · NICHD · UNIVERSITY OF MINNESOTA · PI Craig John Bierle · 2022 to 2026
$2.2M
CTSA Predoctoral T32 at University of MinnesotaT32TR004385 · NCATS · UNIVERSITY OF MINNESOTA · PI Jayne Allyn Fulkerson · 2024 to 2026
$1.3M
NCATS NIH HHS T32 TR004385NCATS NIH HHS UM1 TR004405NIAID NIH HHS U54 AI150225NICHD NIH HHS R01 HD098866NICHD NIH HHS R01 HD109252
6 · The paper itself

Abstract

Human cytomegalovirus (HCMV) is a ubiquitous herpesvirus and the leading cause of infectious disease related birth defects worldwide. How the immune response modulates the risk of intrauterine transmission of HCMV after maternal infection remains poorly understood. Maternal T cells likely play a critical role in preventing infection at the maternal-fetal interface and limiting spread across the placenta, but concerns exist that immune responses to infection may also cause placental dysfunction and adverse pregnancy outcomes. This study investigated the role of CD4+ and CD8+ T cells in a guinea pig model of primary cytomegalovirus infection. Monoclonal antibodies specific to guinea pig CD4 and CD8 were used to deplete T cells in non-pregnant and in pregnant guinea pigs after mid-gestation. CD4+ T cell depletion increased the severity of illness, caused significantly elevated viral loads, and increased the rate of congenital guinea pig cytomegalovirus (GPCMV) infection relative to animals treated with control antibody. CD8+ T cell depletion was comparably well tolerated and did not significantly affect the weight of infected guinea pigs or viral loads in their blood or tissue. However, significantly more viral genomes and transcripts were detected in the placenta and decidua of CD8+ T cell depleted dams post-infection. This study corroborates earlier findings made in nonhuman primates that maternal CD4+ T cells play a critical role in limiting the severity of primary CMV infection during pregnancy while also revealing that other innate and adaptive immune responses can compensate for an absent CD8+ T cell response in α-CD8-treated guinea pigs.

Indexed as

CD4-Positive T-LymphocytesCD8-Positive T-LymphocytesCytomegalovirus InfectionsViral LoadAnimalsCytomegalovirusDisease Models, AnimalFemaleGuinea PigsPregnancyPregnancy Complications, Infectious

Identifiers

PMID39495799
PMCPMC11563410

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.